Effect of Preoperative Incentive Spirometer on Postoperative Pulmonary Complications Following Lung Resection

Sponsor
Milton S. Hershey Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT04732143
Collaborator
(none)
124
1
2
27.1
4.6

Study Details

Study Description

Brief Summary

The objective of this study is to demonstrate that inspiratory muscle training with daily use of an incentive spirometer for at least 14 days prior to lung surgery will reduce the risk of post-operative pulmonary complications.

Condition or Disease Intervention/Treatment Phase
  • Other: Inspiratory muscle training
N/A

Detailed Description

Postoperative pulmonary complications (PPC) are the most common adverse events following lung resection, with a reported incidence of over 20-30% in some series. The objective of this study is to demonstrate that inspiratory muscle training (IMT) with daily use of an incentive spirometer (IS) for at least 14 days prior to lung surgery will reduce the risk of PPCs compared to the usual care, consisting of no formal preoperative IMT. The hypothesis is that preoperative inspiratory spirometer breathing (ISB) is a feasible and cost-effective intervention that can significantly reduce PPCs after lung resection. It is also hypothesized that patient compliance with the intervention will be high because of its simplicity, convenience, low cost and no potential for adverse effects.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
124 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Effect of Preoperative Inspiratory Muscle Training Using Incentive Spirometer on Postoperative Pulmonary Complications Following Lung Resection
Actual Study Start Date :
Apr 27, 2021
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Incentive Spirometry

Participants will undergo inspiratory muscle training using an incentive spirometer daily for 14 days prior to surgery.

Other: Inspiratory muscle training
At least 2 weeks prior to surgery, participants will be given a Vyaire incentive spirometer device and provided with formal training on proper inspiratory muscle breathing exercise using the device. They will be instructed to perform 4 sets of these exercises per day for 14 days prior to surgery.
Other Names:
  • Incentive spirometry
  • No Intervention: Standard Care

    Participants will not undergo any inspiratory muscle training prior to surgery.

    Outcome Measures

    Primary Outcome Measures

    1. Atelectasis [Through completion of follow-up (30 days)]

      Incidence of atelectasis requiring bronchoscopy or additional bedside therapy by a respiratory therapist

    2. Pneumonia [Through completion of follow-up (30 days)]

      Clinical and/or radiographic evidence of pneumonia requiring antibiotic therapy

    3. Respiratory failure [Through completion of follow-up (30 days)]

      Incidence of respiratory failure requiring re-intubation or high flow nasal cannula and/or non-invasive positive pressure ventilation

    4. Pleural effusion [Through completion of follow-up (30 days)]

      Incidence of pleural effusion requiring drainage or other medical intervention (e.g. use of diuretics)

    5. Pneumothorax or subcutaneous emphysema [Through completion of follow-up (30 days)]

      Incidence of clinically significant pneumothorax or subcutaneous emphysema requiring intervention or extended hospital admission for observation

    6. Prolonged air leak [Through completion of follow-up (30 days)]

      Incidence of prolonged air leak (>5 days) or requiring discharge with chest tube

    7. Need for supplemental oxygen [Through completion of follow-up (30 days)]

      Incidence of patients requiring supplemental oxygen upon discharge

    8. Empyema/bronchopleural fistula [Through completion of follow-up (30 days)]

      Incidence of empyema and/or bronchopleural fistula confirmed by fluid analysis and/or cultures

    9. Cardiac arrhythmia [Through completion of follow-up (30 days)]

      Incidence of cardiac arrhythmia requiring intervention (e.g. atrial fibrillation, supraventricular tachycardia, etc.)

    Secondary Outcome Measures

    1. Hospital length of stay [Through completion of follow-up (30 days)]

      Total length of index admission following surgery

    2. ICU length of stay [Through completion of follow-up (30 days)]

      If participant required ICU admission

    3. Chest tube duration [Through completion of follow-up (30 days)]

      Number of days from chest tube insertion (surgery date) until chest tube removal

    4. Hospital readmission [Through completion of follow-up (30 days)]

      Participant visited an emergency department and/or was admitted to the hospital following discharge from the index admission for any reason.

    5. Change from baseline in dyspnea, measured by the modified Medical Research Council scale [Baseline, 2 weeks and 4 weeks after surgery]

      Scores are measured on a scale from 0 to 4, with 0 indicating dyspnea only with strenuous exercise and 4 indicating participant is too dyspneic to leave the house or breathless when dressing

    6. Mortality [Through completion of follow-up (30 days)]

      Death from any cause

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • ECOG performance status score 2 or less

    • Undergoing elective lung resection (includes wedge resection, lobectomy, bi-lobectomy, pneumonectomy, sleeve resection) via minimally invasive (VATS or robotic) approach or thoracotomy

    • Chest wall resection if performed concurrently with lung resection

    Exclusion Criteria:
    • ECOG performance status score greater than 2

    • Significant cognitive impairment preventing informed consent

    • Non-English speaking

    • Wedge biopsy for interstitial lung disease

    • Bullectomy for bullous emphysema

    • Pre-existing tracheostomy

    • Emergent or urgent surgery

    • Preoperative home oxygen use

    • History of neuromuscular disease

    • Prisoners

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Penn State Milton S. Hershey Medical Center Hershey Pennsylvania United States 17033

    Sponsors and Collaborators

    • Milton S. Hershey Medical Center

    Investigators

    • Principal Investigator: Pauline H Go, MD, Milton S. Hershey Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Pauline Go, Associate Professor of Surgery, Milton S. Hershey Medical Center
    ClinicalTrials.gov Identifier:
    NCT04732143
    Other Study ID Numbers:
    • STUDY00015501
    First Posted:
    Feb 1, 2021
    Last Update Posted:
    May 25, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Pauline Go, Associate Professor of Surgery, Milton S. Hershey Medical Center

    Study Results

    No Results Posted as of May 25, 2022